Medical Diagnostics company, developing innovative self-testing and point of care platforms.
Developing therapeutic products to treat gastroenterological diseases and disorders.
* IPO on AIM and LSE in Feb 2006 (LON:AGI).
|Advanced Surgical Concepts
Surgical instruments for use in endoscopy and in minimally invasive surgery.
Biopharmaceutical company developing gene medicines for inherited blindness.
Developing continuous glucose monitoring systems to implement tight glycemic control therapy through insulin delivery for ICU patients.
Medical devices. Developing a therapeutic device to treat patients acute coronary syndrome.
Novel Dental Implant technology.
Developing novel device to improve the outcomes of stroke patients by removing blood clots.
Low light detection solutions with application in medical imaging.
Paris, France and San Francisco, USA
Medical devices. Develops and markets the PediGuard range of instruments which make spinal surgery safer for patients, surgeons and OR staff.
Delta Partners Limited is regulated by the Central Bank of Ireland